Congenital heart disease: Current knowledge about causes and inheritance

Medical Journal of Australia

Volumn 197, Issue 3, 2012, Pages 155-159

  Blue, Gillian M ^a   Kirk, Edwin P ^b   Sholler, Gary F ^a   Harvey, Richard P ^c   Winlaw, David S ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CANNABIS; FOLIC ACID; LITHIUM SALT; RETINOIC ACID; RUBELLA VACCINE; SEROTONIN UPTAKE INHIBITOR; TERATOGENIC AGENT; THALIDOMIDE;

ARTICLE; CARDIOVASCULAR RISK; CHROMOSOME ABERRATION; CONGENITAL HEART DISEASE; COPY NUMBER VARIATION; DOWN SYNDROME; EVIDENCE BASED MEDICINE; FAMILY HISTORY; FETOPLACENTAL UNIT; FETUS CIRCULATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SERVICE; GENOTYPE PHENOTYPE CORRELATION; GLYCEMIC CONTROL; HUMAN; MENDELIAN SYNDROME; MULTIFACTORIAL INHERITANCE; OXIDATIVE STRESS; PERINATAL CARE; PREGNANCY DIABETES MELLITUS; PRENATAL CARE; RECURRENCE RISK; RISK REDUCTION; RUBELLA; SIBLING; SOMATIC MUTATION; VELOCARDIOFACIAL SYNDROME; VITAMIN SUPPLEMENTATION; CONGENITAL HEART MALFORMATION; ENVIRONMENT; GENETIC DISORDER; GENETICS; REVIEW; RISK FACTOR;

CHROMOSOME ABERRATIONS; ENVIRONMENT; GENETIC DISEASES, INBORN; HEART DEFECTS, CONGENITAL; HUMANS; RISK FACTORS; TERATOGENS;

EID: 84867390249     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja12.10811     Document Type: Article

References (29)

1. Wessels MW, Willems PJ. Genetic factors in non-syndromic congenital heart malformations. Clin Genet 2010; 78: 103-123.
2. Khairy P, Ionescu-Ittu R, Mackie AS, et al. Changing mortality in congenital heart disease. J Am Coll Cardiol 2010; 56: 1149-1157.
3. Formigari R, Michielon G, Digilio MC, et al. Genetic syndromes and congenital heart defects: how is surgical management affected? Eur J Cardiothorac Surg 2009; 35: 606-614.
4. Nora JJ. Multifactorial inheritance hypothesis for the etiology of congenital heart diseases: the genetic-environmental interaction. Circulation 1968; 38: 604-617.
5. Merscher S, Funke B, Epstein JA, et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 2001; 104: 619-629.
6. Roos-Hesselink JW, Kerstjens-Frederikse WS, Meijboom FJ, Pieper PG. Inheritance of congenital heart disease. Neth Heart J 2005; 13: 88-91.
7. Pierpont ME, Basson CT, Benson DW Jr, et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115: 3015-3038.
8. Burn J, Goodship J. Congenital heart disease. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR, editors. Emery and Rimoin's principles and practice of medical genetics. 4th ed. London: Churchill Livingstone, 2002: 1239-1272.
9. Lin AE, Ardinger HH. Genetic epidemiology of cardiovascular malformations. Prog Pediatr Cardiol 2005; 20: 113-126.
10. American Academy of Pediatrics Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics 2001; 107: 442-449.
11. Botto LD, May K, Fernhoff PM, et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003; 112: 101-107.
12. Soemedi R, Topf A, Wilson IJ, et al. Phenotype-specific effect of chromosome 1q21.1 rearrangements and GJA5 duplications in 2436 congenital heart disease patients and 6760 controls. Hum Mol Genet 2012; 21: 1513-1520.
13. van der Bom T, Zomer AC, Zwinderman AH, et al. The changing epidemiology of congenital heart disease. Nat Rev Cardiol 2011; 8: 50-60.
14. Butler TL, Esposito G, Blue GM, et al. GATA4 mutations in 357 unrelated patients with congenital heart malformation. Genet Test Mol Biomarkers 2010; 14: 797-802.
15. Jongbloed JD, Pósafalvi A, Kerstjens-Frederikse WS, et al. New clinical molecular diagnostic methods for congenital and inherited heart disease. Expert Opin Med Diagn 2011; 5: 9-24.
16. Wren C, Birrell G, Hawthorne G. Cardiovascular malformations in infants of diabetic mothers. Heart 2003; 89: 1217-1220.
17. Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115: 2995-3014.
18. Cousins L. Etiology and prevention of congenital anomalies among infants of overt diabetic women. Clin Obstet Gynecol 1991; 34: 481-493.
19. Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C Semin Med Genet 2004; 125C: 12-21.
20. Wurst KE, Poole C, Ephross SA, Olshan AF. First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies. Birth Defects Res A Clin Mol Teratol 2010; 88: 159-170.
21. Hove JR, Koster RW, Forouhar AS, et al. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 2003; 421: 172-177.
22. Kirk EP, Sunde M, Costa MW, et al. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet 2007; 81: 280-291.
23. Esposito G, Butler TL, Blue GM, et al. Somatic mutations in NKX2-5, GATA4, and HAND1 are not a common cause of tetralogy of Fallot or hypoplastic left heart. Am J Med Genet A 2011; 155A: 2416-2421.
24. Calcagni G, Digilio M, Sarkozy A, et al. Familial recurrence of congenital heart disease: an overview and review of the literature. Eur J Pediatr 2007; 166: 111-116.
25. Burn J, Brennan P, Little J, et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 1998; 351: 311-316.
26. Nora JJ, Nora AH, Optiz JM, Reynolds JF. Update on counseling the family with a first-degree relative with a congenital heart defect. Am J Med Genet 1988; 29: 137-142.
27. Lewin MB, McBride KL, Pignatelli R, et al. Echocardiographic evaluation of asymptomatic parental and sibling cardiovascular anomalies associated with congenital left ventricular outflow tract lesions. Pediatrics 2004; 114: 691-696.
28. Kerstjens-Frederikse WS, Du Marchie Sarvaas GJ, Ruiter JS, et al. Left ventricular outflow tract obstruction: should cardiac screening be offered to first-degree relatives? Heart 2011; 97: 1228-1232.
29. Gill HK, Splitt M, Sharland GK, Simpson JM. Patterns of recurrence of congenital heart disease: an analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. J Am Coll Cardiol 2003; 42: 923-929.